These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 16956602)

  • 1. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function.
    Risch L; Saely C; Hoefle G; Rein P; Langer P; Gouya G; Marte T; Aczel S; Drexel H
    Clin Chim Acta; 2007 Feb; 376(1-2):108-13. PubMed ID: 16956602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adipokines: adiponectin, leptin, resistin and coronary heart disease risk].
    Kopff B; Jegier A
    Przegl Lek; 2005; 62 Suppl 3():69-72. PubMed ID: 16521924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
    Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
    Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocytokines and breast cancer risk.
    Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
    Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
    Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
    Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
    Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating resistin concentrations in children depend on renal function.
    Nüsken KD; Kratzsch J; Wienholz V; Stöhr W; Rascher W; Dötsch J
    Nephrol Dial Transplant; 2006 Jan; 21(1):107-12. PubMed ID: 16144855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.
    Gouni-Berthold I; Berthold HK; Chamberland JP; Krone W; Mantzoros CS
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):536-41. PubMed ID: 17973945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytokines are associated with renal function in patients with normal range glomerular filtration rate and type 2 diabetes.
    Barlovic DP; Zaletel J; Prezelj J
    Cytokine; 2009 Apr; 46(1):142-5. PubMed ID: 19223200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
    Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
    Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men.
    Oh KW; Lee WY; Rhee EJ; Baek KH; Yoon KH; Kang MI; Yun EJ; Park CY; Ihm SH; Choi MG; Yoo HJ; Park SW
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):131-8. PubMed ID: 16060905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splanchnic concentrations and postprandial release of visceral adipokines.
    Wiest R; Moleda L; Farkas S; Scherer M; Kopp A; Wönckhaus U; Büchler C; Schölmerich J; Schäffler A
    Metabolism; 2010 May; 59(5):664-70. PubMed ID: 19913846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction.
    Mitsnefes M; Kartal J; Khoury P; Daniels S
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):46-50. PubMed ID: 17699386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
    Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
    Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between adipokines and manifestations of childhood asthma.
    Kim KW; Shin YH; Lee KE; Kim ES; Sohn MH; Kim KE
    Pediatr Allergy Immunol; 2008 Sep; 19(6):535-40. PubMed ID: 18221467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension.
    Barac A; Campia U; Matuskey LA; Lu L; Panza JA
    Am J Cardiol; 2008 Apr; 101(7):980-5. PubMed ID: 18359318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.